Monday Morning Movers

Conatus Pharmaceuticals Inc CNAT +40% - The company announced plans to report top-line results of its clinical trials of Emricasan on January 8th.

Cempra Inc. CEMP +12% - On Sunday, the company announced positive results from its pneumonia study; meeting primary and secondary objectives.

Immunomedics Inc. IMMU +7% - Shares are higher after the company won fast track designation for its IMMU-132 drug.

Cerus Corporation CERS +5.1% - The company announced that its EU Phase 3 trial of INTERCEPT met primary endpoint.

ISIS Pharmaceuticals Inc. ISIS +3.7% - The company announced a deal with Johnson & Johnson’s Janssen Biotech Inc.

El Pollo LoCo Holdings Inc. LOCO +3.2% - Analysts at Baird upgraded shares of El Pollo Loco to Outperform.

Brainstorm Cell Therapeutics BCLI -8% - Shares are lower following the company’s announcement of its final analysis of its phase 2a ALS study.

Starbucks Corporation SBUX -1.4% - On Monday, analysts at Janney Capital downgraded Starbucks shares to Neutral and lowered the price target to $85.

Amgen Inc AMGN -1.1% - Shares were downgraded to Equal-weight at Morgan Stanley.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market Outlook
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!